CONMED Number of Employees 2010-2024 | CNMD

CONMED number of employees from 2010 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
CONMED Annual Employee Count
2023 4,000
2022 4,100
2021 3,800
2020 3,400
2019 3,300
2018 3,100
2017 3,100
2016 3,300
2015 3,400
2014 3,500
2013 3,600
2012 3,600
2011 3,400
2010 3,300
2009 3,500
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.190B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.685B 21.51
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $24.405B 13.95
West Pharmaceutical Services (WST) United States $24.275B 43.51
Align Technology (ALGN) United States $19.273B 37.21
Cooper (COO) United States $18.612B 27.45
Labcorp (LH) United States $16.850B 14.51
Henry Schein (HSIC) United States $8.426B 14.99
DENTSPLY SIRONA (XRAY) United States $5.421B 14.04
Merit Medical Systems (MMSI) United States $4.753B 26.05
Patterson (PDCO) United States $2.027B 9.71
STAAR Surgical (STAA) United States $2.025B 77.77
Atrion (ATRI) United States $0.794B 42.40
Lifevantage (LFVN) United States $0.088B 11.31
Pro-Dex (PDEX) United States $0.066B 33.31
Biolase (BIOL) United States $0.005B 0.00